Programme

WHAT IS THE AIM AND OBJECTIVE OF 2017 MEDICAL CANNABIS CONFERENCE?

The expert conference on medical cannabis and cannabinoids is a forum for scientists and other experts, practitioners in the field such as medical doctors, pharmacists, medical nurses and other medical staff, for patient activists, for decision makers and for general public – and last but not least, the media. The main objective of the conference is to bring the latest information and best practices on introduction of medical cannabis into modern evidence-based medicine and to help to establish the use of medical cannabis as a standard medical procedure.

Scientific Programme 

There are new speakers coming up - like us on Facebook, follow us on Twitter or sign up for email updates at the homepage.


Wednesday, 22 November 2017

TimeHall AHall BHall C
9:30 – 11:00

OPENING

Chair: 

Jindřich VobořilNational Drug Coordinator of the Czech Republic 


KEYNOTE SPEAKERS

Michel Kazatchkine (member of the Global Commission on Drug Policy, and United Nations Special Envoy for AIDS in Eastern Europe and Central Asia)

Steph Sherer (Americans for Safe Access, and International Medical Cannabis Patients Consortium)

Ben Bronfman (Discorides Global Holdings)

Svatopluk Němeček (Czech Minister of Health 2014-2016, and Director of the Faculty Hospital in Ostrava)

Miloslava Němcová (Member of the Chamber of Commons, Czech Parliament)

Lumir Ondřej Hanuš (Hebrew University in Jerusalem, and The Lambert Center for the Study of Medicinal Cannabis and Hemp, Thomas Jefferson University, Philadelphia, USA)

Steven Gust (National Institute on Drug Abuse, USA)

Mark Ware (McGill University, and chair of the International Association for Cannabinoids Medicines.

Ethan Russo (Phytecs, Inc.)

11:00 – 11:20COFFEE BREAK ​ ​
​11:20 – 12:50

Medical cannabis regulation systems in the EU: rules, implementation, outputs


​Medical cannabis regulation systems in the Americas, Australia, and Israel: rules, implementation, known and expected outputs

Medical cannabis regulation systems outside of the “western world”: rules, implementation, known and expected outputs

 

Chair: 

Ingo Ilja Michels (Germany) / Brendan Hughes (EMCDDA)



Speakers:

Representatives of the National Medical Cannabis Agencies of the EU Member States


Chair:

Mark Ware (McGill University and IACM) / Nicola Singleton (EMCDDA)


Speakers:

Representatives of the Americas, Australia, and Israel


Chair:
Pavel Bem (GDC) / Steph Sherer (ASA and IMCPC)





Speakers:

Representatives of the National Medical Cannabis Agencies of the respective countries 




12:50 – 13:20
LUNCH BREAK 
13:30 – 15:00

PLENARY SESSION: A PLANT FULL OF INTERRELATED MOLECULES: DOES ONE RESEARCH PARADIGM FIT FOR THE ENTOURAGE EFFECT, TOO? 

Chair:

Lumír Ondřej Hanuš (Hebrew University in Jerusalem and ICCI) 


Speakers:

Ethan Russo (Phytecs, Inc, formerly GW Pharmaceuticals)

Pal Pacher (National Institute on Alcohol Abuse and Alcoholism, NIH)

Tomáš Zábranský (Chief Scientist, ICCI) ​

​15:00 – 15:20
COFEE BREAK
​15:20 – 16:50
​PLENARY SESSION: WHAT REGULATION, WHAT AIMS, WHAT RESULTS, WHAT RECOMMENDATIONS - REPORTING FROM THE PARALLEL SESSIONS

Chair: 
Michel Kazatchkine & Jindřich Vobořil

Speakers:
Ingo I. Michels, Brendan Hughes, Mark Ware, Nicola Singleton, Pavel Bem, Steph Sherer


16:00 – 18:00WELCOME RECEPTION ​ ​

Thursday, 23 November 2017

TimeHall AHall BHall C
9:30 – 10:30
PLENARY: CLINICAL RESEARCH AND CANNABIS: EVIDENCE BASED MEDICINE AND ITS LIMITATIONS

Chair:

Alan Frankel (Greenbridge Medical Services)  

Dustin Sulak (Integr8)


Speakers:​ ​

Mark Ware (McGill Uni & IACM)

Steven Gust (NIDA)


10:30 – 10:45
COFFEE BREAK ​ ​
10:45 – 12:15
WORKSHOP

Cannabis, cannabinoids and cancer(s): where are we going


Prof. Jan Žaloudík
Alan Frankel

WORKSHOP
Czech Republic, Central Europe and Cannabis in the doctor's office


Dr. Radovan Hřib
Eva Dokoupilová (rheumatologist, Chief medical doctor at the ambulatory services Medical Plus)
WORKSHOP

Educate your doctor (No one would do it for you)


Richard Rokyta
Steph Sherer

12:15 – 13:45
LUNCH BREAK
NETWORKING LUNCH
13:45 – 15:15
PLENARY: WHAT THE PATIENTS NEED AND WHAT THEY NEED TO DO WITH IT

Ms. Steph Sherer
Ms. Hana Vagnerova

Representatives of patients’ organizations (21 national organizations syndicated in IMCPC, plus others)


15:15 – 16:00COFFEE BREAK ​ ​
16:00 – 17:30
WORKSHOP
Controversies and needs in clinical studies in cannabis and cannabinoids



Ethan Russo (Phytecs, Inc.), Dustin Sulak, Alan Frankel, Tomas Zabransky (ResAd and ICCI), + other discussants based on abstracts selection


WORKSHOP
Studies of medical cannabis policies: achievements, failures, pitfalls.



Alex Stevens (University of Kent, President of the ISSDP), Beau Kilmer (RAND Corporation, USA - TBC)




WORKSHOP
Translational research of cannabinoids - from preclinical studies to possible clinical use

Alexandra Šulcová (Medical Faculty, Masaryk University in Brno)

17:30 – 20:00
PLENARY DISCUSSION (WORKING DINNER)
IS EU A PASTURE FOR MEDICAL CANNABIS CASH COWS?
Benjamin Bronfman (DGH), Miri Halperin Wernli (Creso Pharma)

Friday, 24 November 2017

TimeHall AHall BHall C
9:30 – 11:00PLENARY SESSION: MEDICAL CANNABIS POLICIES AND UN/INTENDED CONSEQUENCES

Chair:
Dr. Nicola Singleton

Speakers:
Alex Stevens (Kent Uni, ISSDP)
Beau Kilmer (RAND Corporation, USA)
Simon Lenton (National Drug Research Institute, Curtin University)
11:00 – 11:20COFFEE BREAK ​ ​
11:20 – 13:00PLENARY: PRAGUE MEDICAL CANNABIS DECLARATION 2017

Medical Cannabis and Cannabinoids in the 21st century:
What the medicine and the global control régime is to do

Chair: 
Steph Sherer

Speakers:
Richard Rokyta (President of the Czech Medical Academy)
Michel Kazatchkine (GCDP)
Pavel Bém (GCDP)
Tomas Zabransky (ICCI)
Hana Vagnerová (KOPAC)
13:00 – 14:30LUNCH BREAK
14:30 – 16:00WORKSHOP
How the evidence-based medicine can learn from successful causal treatment cases of natural healers

Dustin Sulak (integr8), Tomas Zabransky (ICCI), Jindrich Bayer, MA

WORKSHOP
The Medical Cannabis Access Research Priority Mapping




Steph Sherer (ICCI), Tomas Zabransky (ResAd, ICCI), Ethan Russo (Phytecs)








DEBATE
How the investors should invest wisely to avoid the “big cannabis bubble?”


TBS


16:00 – 17:00

CLOSING CEREMONY AND RECEPTION
Announcement of IMCCC 2018, records publication, signatory lists and e-petition supporting Prague Declaration


Tomáš Zábranský (ResAd, ICCI)
Steph Sherer (ICCI)
Lumir O. Hanuš (HIJ & LCSMCH)





Keep Me Updated